Changes in Management of Biotage AB

Changes in Management of Biotage AB

Erika Söderberg Johnson has been appointed as the new CFO and Business
Controller of Biotage AB. She will start her assignment on 1 January
2012. Erika has been the CFO of Karo Bio AB since 2007.

Mats-Olof Wallin, the present CFO of Biotage, is leaving the company at
his own request and he remains at his position until Erika Söderberg
Johnson starts. Mats-Olof started as CFO at Pyrosequencing AB (which
later was changed to the name Biotage AB) 1 February 2003.

”Biotage has undergone many and large changes during the period
Mats-Olof has been with the company, such as a number of acquisitions of
both products and companies with the following post-merger work, not to
forget the sale of the Biosystems division (previously known as
Pyrosequencing). I want to express my gratitude for Mats-Olof 's efforts
and contributions both in the role as CFO but also in the business
development activities involved. I wish Mats-Olof all the best for the
future.”, says Torben Jørgensen, CEO, Biotage AB.

 
Contact:
Torben Jörgensen, President and CEO
Tel: +46 707 49 05 84,
torben.jorgensen@biotage.com (torben.jorgensen@biotage.com)

The information in this press release is of the kind that Biotage AB
(publ) may be required to make public according to the Securities Market
Act and/or Financial Instruments Trading Act. The information was
released for publication at 8am on October 26, 2011.

About Biotage:
Biotage offers solutions, knowledge and experience in the areas of
analytical chemistry and medicinal chemistry. The customers include the
world's largest pharmaceutical and biotech companies, and leading
academic institutes. The company is headquartered in Uppsala and has
subsidiaries in the US, UK and Japan. Biotage has 272 employees and had
sales of 428.9 MSEK in 2010. Biotage is listed on the NASDAQ OMX Nordic
Stockholm stock exchange.
Website:www.biotage.com (http://www.biotage.com/)